7 results
6-K
EX-99.1
GMAB
Genmab
14 Feb 24
Genmab 2023 Annual Report
12:30pm
to innovate and find new ways to help patients. Denmark Genmab introduced our own Good Manufacturing Practice (GMP) QC laboratory in 2023. The new space
6-K
EX-99.1
GMAB
Genmab
14 Feb 24
Genmab 2023 Annual Report
12:30pm
brainstorming and meeting rooms. They provide a bright, open, and collaborative atmosphere and enable the Genmab team to continue to innovate and find new ways
6-K
EX-99.1
GMAB
Genmab
16 Feb 22
Genmab 2021 Annual Report
11:29am
antibody science at the deepest level, in combination with an inherent drive to innovate discovery and development practices.
Research and Development … to innovate and find new ways to help patients. In order to accommodate Genmab’s growth, we will occupy the majority of the new “Accelerator” multi-tenant
6-K
EX-99.1
GMAB
Genmab
16 Feb 22
Genmab 2021 Annual Report
11:29am
with an inherent drive to innovate discovery and development practices. Aran Labrijn, Director, Antibody Format Discovery Lead, the Netherlands 21 2021 … to continue to innovate and find new ways to help patients. In order to accommodate Genmab’s growth, we will occupy the majority of the new “Accelerator
6-K
EX-99.1
GMAB
Genmab
23 Feb 21
Genmab 2020 Annual Report
12:38pm
, this space provides a bright, open and collaborative atmosphere to enable the Genmab team to continue to innovate and find new ways to help cancer
6-K
EX-99.1
vrm0qb
23 Feb 21
Genmab 2020 Annual Report
12:38pm
6-K
EX-99.1
ickso179
19 Feb 20
Innovating antibodies, improving lives Annual Report 2019 Genmab A/S CVR No. 21 02 38 84
1:28pm
- Prev
- 1
- Next